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Abstract: The International Association for Intelligent Biology and Medicine (IAIBM) is a nonprofit
organization that promotes intelligent biology and medical science. It hosts an annual International
Conference on Intelligent Biology and Medicine (ICIBM), which was established in 2012. The ICIBM
2019 was held from 9 to 11 June 2019 in Columbus, Ohio, USA. Out of the 105 original research
manuscripts submitted to the conference, 18 were selected for publication in a Special Issue in Genes.
The topics of the selected manuscripts cover a wide range of current topics in biomedical research
including cancer informatics, transcriptomic, computational algorithms, visualization and tools, deep
learning, and microbiome research. In this editorial, we briefly introduce each of the manuscripts and
discuss their contribution to the advance of science and technology.
Keywords: cancer informatics; clustering algorithm; single cell omics; transcriptomic analysis and
tools; statistical methods; microbiome research
1. Introduction
The International Conference on Intelligent Biology and Medicine (ICIBM 2019) was organized
and hosted by the International Association for Intelligent Biology and Medicine (IAIBM) and the
Department of Biomedical Informatics at Ohio State University from 9 to 11 June 2019 in Columbus,
Ohio, USA. The detailed description of the conference and its organization and achievements is
summarized in [1]. The conference attracted 164 researchers and over 100 manuscripts with broad
scientific topics were submitted. Each manuscript went through ICIBM internal peer review by a
minimum of two reviewers. Manuscripts selected for publication in the Special Issue in Genes were
further reviewed by a minimum of two additional external reviewers. In the end, 18 manuscripts
were selected for publication in the Special Issue, which covered the topics of cancer research, gene
expression, single cell sequencing, novel computational algorithms, and microbiome research. In this
editorial, we introduce the 18 selected research manuscripts.
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2. Cancer Informatics
Chen et al. published “Computational Cancer Cell Models to Guide Precision Breast Cancer
Medicine” [2]. In this work, the authors introduced an optimal two-layer decision system model for
predicting drug sensitivity. The practical application of this model resides in precision or personalized
medicine that attempts to address the bridge between conventional in vitro cancer cell models and
clinical patient response to cancer drugs, which is still lacking. This model obtained an average
accuracy of 90.8% using the simulated data. In conclusion, this two-layer model could be easily
extended to multiple cancer types and it could help basic scientists who are seek optimal cancer cell
models for an individual tumor while prioritizing clinical drugs’ recommendations in practice.
A pathway is a summary of a set of genes that can be connected via their biological process,
regulation, mechanism. or phenomenon. Pathways of important function can be alternatively activated
in cancer. Wang et al. published “Identification of Alternatively-Activated Pathways between Primary
Breast Cancer and Liver Metastatic Cancer Using Microarray Data”, in which the authors proposed an
alternatively-activated pathway mining method [3] based on microarray data, and identified three
types of alternatively-activated pathways between primary breast cancer and breast liver metastatic
cancer. There were three types of alternatively-activated pathways that were identified through their
analysis as follows: active states of some gene pairs were inversed, some subpathways were only
active in primary cancer or metastatic cancer, and some subpathways were alternatively-activated by
different genes.
Circulating tumor DNA (ctDNA) has been found in the bloodstream which originated from
cancerous cells. Research on ctDNA has been expanding over the last decade resulting in substantial
advancement in the identification of single nucleotide variants from ctDNA. Copy number variation
(CNV), which is also considered to be an important cancer biomarker, has been very difficult to detect
from ctDNA due to the low amount and complex CNV features. Peng et al. published “CNV Detection
from Circulating Tumor DNA in Late-Stage Non-Small Cell Lung Cancer Patients” to address the
critical issue of CNV identification in ctDNA [4]. Their method could detect CNVs from a 150-gene
panel using a very low amount of ctDNA.
DNA methylation plays a variety of roles in cancer, including a critical role in the control of gene
activity, which helps to convert gene expression in normal tissue to a cancerous pattern. Utilizing deep
learning techniques, Liu et al. published “DNA Methylation Markers for Pan-Cancer Prediction by
Deep Learning”, in which they studied the prognostic value of DNA methylation [5]. Using data from
27 cancer types covering 10,140 cancer samples and 3386 normal samples, the authors identified the
following two categories of markers: 12 CpG markers and 13 promoter markers. The results were
validated using cell-free DNA methylation data of 163 prostate cancer samples and they achieved
excellent sensitivity and specificity. This study indicates that the identified biomarkers can be utilized
in both cancer tissue and a cell-free setting.
Gene fusion describes hybrid genes that are formed from two independent genes. Gene
fusion has been a common feature in cancer genomes and has served as a molecular target in
therapeutic development. In Helm et al.’s “Gene Co-Expression Networks Restructured Gene Fusion
in Rhabdomyosarcoma Cancers”, the authors studied gene fusion features in rhabdomyosarcoma [6].
In this study, the authors utilized co-expression network to study fusion between FOXO1 and
PAX3/7 and observed substantial restructuring of co-expression networks related to fusion status and
fusion type.
Tumor-infiltrating leukocytes (TILs) are immune cells surrounding tumor cells, and several studies
have shown that TILs are potential survival predictors in several types of cancers including liver cancer,
which is highly associated with a hepatitis virus. Hsiao et al. studied TIL abundance and compositions
concerning hepatocellular carcinomas survival in their manuscript, entitled “Tumor-Infiltrating
Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular
Carcinomas” [7]. The authors found that the total abundance of TILs was higher in non-tumor tissue
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regardless of the HCC subtype. Alternatively, the specific TILs associated with overall survival (OS)
and recurrence-free survival (RFS) varied between subtypes.
Network and biomarker analyses have been heavily utilized for cancer research. Liu et al.
combined the concept of both a network and biomarker approach in their paper entitled “Network as
a Biomarker: A Novel Network-Based Sparse Bayesian Machine for Pathway-Driven Drug Response
Prediction” [8]. The authors developed a network-based sparse Bayesian machine (NBSBM) approach,
which attempted to use a network as a drug response biomarker. NBSBM made use of the information
encoded in a disease-specific (differentially expressed) network to improve its prediction performance
in problems with a reduced amount of training data and a very high-dimensional feature space.
This method provides a disease-specific network-based drug sensitivity prediction approach and can
uncover the potential mechanisms of the action of drugs by selecting the most predictive sub-networks
from the disease-specific network.
In the paper entitled “Kinetic Modeling of DUSP Regulation in Herceptin-Resistant HER2-Positive
Breast Cancer”, Buiga et al. focused on the analysis of dual-specificity phosphatases (DUSPs) in
HER2-positive breast cancer [9], a highly aggressive subtype of breast cancer. The authors investigated
whether inhibiting certain DUSPs resensitized Herceptin-resistant breast cancer cells to the drug by
building kinetic models. The authors observed good concordance between their model and real tumor
data. Their data shows that kinetic modeling of signaling pathways can generate predictions that assist
experimental research in the identification of potential targets for cancer treatment.
3. Clustering Algorithm
Compelling evidence has shown that microRNAs (miRNAs) can regulate genes and be
associated with various cancers through a post-transcriptional suppression regulation mechanism.
The dysregulation of miRNA can substantially alter the landscape of the transcriptome level of
messenger RNAs (mRNAs). Dai et al. published “Identifying Interaction Clusters for miRNA and
mRNA Pairs in TCGA Network”, which describes a novel cluster scoring method to identify mRNA
and miRNA interaction pairs [10]. Their analysis identified 54 significant clusters in 15 cancer types
using the data from The Cancer Genome Atlas (TCGA) project.
Cryogenic electron microscopy (cryoEM) is an electron microscopy technique applied on samples
cooled to cryogenic temperatures and embedded in an environment of vitreous water. It is often used
to study structural biology. The analysis of cryoEM often involves a clustering algorithm. Al-Azzawi et
al. published “A Super-Clustering Approach for Fully Automated Single Particle Picking in Cryo-EM”,
a manuscript that describes a newly developed fully automated super-clustering algorithm for single
particle picking in cyroEM micrographs. The authors focused on identifying, detecting, and picking
particles of the complex and irregular shapes in micrographs with extremely low signal-to-noise
ratio [11].
4. Single Cell Omics
While single cell sequencing has quickly emerged as a powerful technology for measuring DNA
variants or transcriptome abundance at the single cell resolution, numerous challenges currently
remain in this new field. One of the major shortcomings of single cell RNA-seq is the excessive zero
counts, because only a small fraction of the transcripts sequenced in each cell. This problem can be
alleviated by sequencing more, but it is at a high financial cost and also a lack of enough cells available
for sequencing. The sparsity of the gene expression for each cell creates additional downstream
analysis challenges such as cell type identification. Zand et al. introduced a network-based method,
netImpute [12] to battle this problem in their manuscript, entitled “Network-Based Single-Cell RNA-Seq
Data Imputation Enhances Cell Type Identification”. The netImpute method employs the random walk
with the restart algorithm to adjust the gene expression level in a given cell by borrowing information
from its neighbors in a gene co-expression network. Evaluation of seven real datasets showed that
netImpute substantially enhanced cell type clustering accuracy and data visualization clarity. Mallik
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et al. published “Multi-Objective Optimized Fuzzy Clustering for Detecting Cell Clusters from
Single-Cell Expression Profiles”, a study about cell clusters with a multi-objective optimization-based
fuzzy clustering approach [13]. The authors demonstrated the approach in several real datasets and
showed the usefulness of the method in detecting cell clusters from single cell RNA-seq data.
5. Transcriptomic Analysis and Tools
In the era of big data, data visualization tools are essential for analyzing massive amounts of
information and making data-driven decision. This is no difference in transcriptomic data analysis.
Al-Ouran et al. published “A Portal to Visualize Transcriptome Profiles in Mouse Models of Neurological
Disorders”, in which they described a new web-based platform for visualizing mouse transcriptome
data [14]. The web portal was developed to help with nominating the best mouse models for studying
neurological diseases. The portal can be used to examine gene expression changes across multiple
mouse model studies including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease,
Amyotrophic Lateral Sclerosis, Spinocerebellar ataxia, and aging-related diseases.
Non-coding RNA has been the focus of many research studies over the last decade. Porto et al.
published “Long Non-Coding RNA Expression Levels Modulate Cell-Type-Specific Splicing Patterns
by Altering Their Interaction Landscape with RNA-Binding Proteins”, a study [15] in which the authors
explored the role of lncRNAs in modulating alternative splicing and their impact on downstream
protein–RNA interaction networks. On the basis of the analysis results, the authors proposed that such
lncRNA sponges could extensively rewire post-transcriptional gene regulatory networks by altering
the protein–RNA interaction landscape in a cell-type-specific manner.
A circadian rhythm is a natural internal process that regulates the sleep-wake cycle. While
the canonical circadian clock genes and their regulatory mechanisms appear highly conserved, the
evolution of clock gene families is still unclear due to several rounds of whole genome duplication
in vertebrates. Sun et al. studied circadian clock genes in spotted gar, a non-teleost ray-finned fish,
and published their findings in the manuscript “The Molecular Evolution of Circadian Clock Genes in
Spotted Gar (Lepisosteus oculatus)” [16]. Phylogenetic analysis showed that nine of these 11 spotted gar
circadian clock gene families have the same number of genes as humans, while the members of the
nfil3 and cry families are different between spotted gar and humans. These findings help decipher the
repertoires of the spotted gar’s circadian system and shed light on how the vertebrate circadian clock
systems have evolved.
6. Statistical Methods
In data science, a large dataset is often assembled from multiple smaller datasets with heterogeneity.
The missing variable has become a common problem when combining datasets, which poses a major
challenge for downstream analysis. Bartlett et al. published “Forming Big Datasets through Latent Class
Concatenation of Imperfectly Matched Databases Features”, to address this problem [17]. The authors
introduced ROSETTA, a statistical method to address missing variables. It empirically derives a set of
common latent trait metrics for each related measurement domain using a novel variation of factor
analysis to ensure equivalence across the constituent datasets. The advantages of combining datasets
this way are the simplicity, statistical power, and modeling flexibility of a single joint analysis of all
the data.
Genotyping data has been aiding researchers for large genetic association studies for the last two
decades. Imputation is an important preprocessing step for combining genotyping data or increasing
coverage. Traditional genotype imputation methods are typically based on haplotype-clustering
algorithms, hidden Markov models (HMMs), and statistical inference. Chen et al. described their new
deep learning-based imputation method [18] in their manuscript “Sparse Convolutional Denoising
Autoencoders for Genotype Imputation”. The authors proposed a deep learning model named a sparse
convolutional denoising autoencoder to impute missing genotypes. Their method showed strong
robustness and outperformed popular reference-free imputation methods.
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7. Microbiome Research
The microbiome studies many microorganisms in a particular environment. Microbiome research
has been greatly enhanced by the advancement of 16S rRNA high throughput sequencing. Liu et al.
published “Changes in the Microbial Community Diversity of Oil Exploitation”, a study on microbiome
in several offshore petroleum production sites [19]. The authors observed a decrease of microbial
community richness and diversity in petroleum mining, and the microbial community structure
was strongly affected. Their study revealed that the various microbiomes produced surfactants,
transforming the biohazard and degrading hydrocarbon. Altering the microbiome growth condition
by appropriate human intervention and taking advantage of natural microbial resources can further
enhance oil recovery technology.
8. Conclusions
ICIBM is an annual international conference, which has been held every year since 2012 (except
2017). It promotes a highly interactive and friendly platform for both young and senior researchers to
exchange their research, foster collaboration, as well as expand educational activities. Approximately
one hundred and seventy researchers and trainees from around the world joined the 2019 conference
and contributed to a rich conference program, which included four keynote lectures, four eminent
scholar talks, five tutorials and workshops, twelve concurrent sessions, a poster session, and other
conference activities. Among the 105 original research manuscripts, we selected 18 for the Special Issue
after two rounds of peer reviews. These 18 manuscripts describe innovative, computational works in
the field. We expect these manuscripts to promote further investigation in the same or similar topics,
and lead to more research toward translational clinical applications.
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